← Back to Search

Behavioural Intervention

BT-001 for Type 2 Diabetes

Phase 3
Waitlist Available
Research Sponsored by Better Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and day 180
Awards & highlights

Study Summary

This trial is testing a software program, BT-001, to see if it can help patients with type 2 diabetes improve their glycemic control by changing behaviors related to blood sugar levels.

Eligible Conditions
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and day 180
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and day 180 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The difference in the mean change from baseline in HbA1c at Day 90 between Intervention and Standard of Care groups
Secondary outcome measures
The difference in the mean change from baseline in HbA1c at Day 180 between Intervention and Standard of Care groups

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BT-001 + Standard of CareExperimental Treatment2 Interventions
BT-001 is a software program used with physician guidance, being investigated to improve glycemic control. Patients randomized to this arm of the study will interact with the BT-001 software program in addition to receiving Standard of Care for type 2 diabetes
Group II: Standard of CareActive Control1 Intervention
Patients randomized to the Standard of Care arm will receive Standard of Care treatment for type 2 diabetes under the guidance of a physician
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BT-001
2021
Completed Phase 3
~670

Find a Location

Who is running the clinical trial?

Better TherapeuticsLead Sponsor
4 Previous Clinical Trials
1,098 Total Patients Enrolled
Mark Berman, MDStudy DirectorBetter Therapeutics
1 Previous Clinical Trials
118 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes
2021. "Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04886388.
~167 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top